Chinook Therapeutics, Inc.

Ownership Transactions Reported by 15 Insiders

Industry
Pharmaceutical Preparations
Location
400 Fairview Avenue North, Suite 900, Seattle, Washington

There are no Buy or Sell transactions made by insiders since 9/9/2023

Chinook Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Versant Venture Capital VII, L.P. 10%+ Owner $114M Apr 4, 2022
Ross Haghighat Director $4.86M May 26, 2023
Alan Glicklich Chief Medical Officer $308K Feb 10, 2022
William M. Greenman Director Aug 11, 2023
Davis Jerel Director Aug 11, 2023
Tom Frohlich Chief Operating Officer Aug 11, 2023
Eric Dobmeier President, CEO, Director Aug 11, 2023
Dolca Thomas Director Aug 11, 2023
Andrew James King Chief Scientific Officer Aug 11, 2023
Mahesh Krishnan Director Aug 11, 2023
Andrew Oxtoby Chief Commercial Officer Aug 11, 2023
Michelle Renee Griffin Director Aug 11, 2023
Robert Azelby Director Aug 11, 2023
Eric Bjerkholt Chief Financial Officer Aug 11, 2023
Srinivas Akkaraju Director Aug 11, 2023

Recent Insider Transactions by Companies or Individuals for Chinook Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.